Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856219 · ClinicalTrials.gov registry record · Phase 1
Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects
A Phase 1 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00856219 is a Phase 1 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 12 participants.
The verdict
NCT00856219, a Phase 1 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune system may respond differently when receiving continuous TF as compared to receiving intermittent TF. Heart rate variability (HRV, the intervals between heartbeats) is a measurement of the nervous system's response to a stress/illness. The differences in immune cells and/or HRV may influence how the body reacts to complications such as infection.
Interventions
- DIETARY_SUPPLEMENT Enteral Continuous
- DIETARY_SUPPLEMENT Enteral Intermittent
- DIETARY_SUPPLEMENT Parenteral Continuous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00856219
The ClinicalTrials.gov registry entry for NCT00856219 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Enteral Continuous is the first listed.
NCT00856219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00856219 about?
NCT00856219 is a clinical study titled "Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects". Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune s...
What is the current status of trial NCT00856219?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2009-02. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00856219?
The interventions under investigation include: Enteral Continuous (DIETARY_SUPPLEMENT), Enteral Intermittent (DIETARY_SUPPLEMENT), Parenteral Continuous (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00856219?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.